Zachary V Samuels

Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM

Jason S. Lewis, N. Cheung, A. Piersigilli, 2021, The Journal of Nuclear Medicine.

PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes

Y. Reshetnyak, O. Andreev, Jason S. Lewis, 2022, Frontiers in Oncology.

Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3

C. Rudin, M. Morris, Jason S. Lewis, 2022, The Journal of Nuclear Medicine.

Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer

C. Rudin, M. Morris, Jason S. Lewis, 2022, Proceedings of the National Academy of Sciences of the United States of America.

PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models.

T. Reiner, J. Bargonetti, G. Xiao, 2021, Molecular pharmaceutics.

Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer exhibits antitumor efficacy with low toxicity.

C. Rudin, W. Travis, Jason S. Lewis, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers

S. Monette, Zachary V Samuels, S. S. Panikar, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer

Kyeara N. Mack, Zachary V Samuels, P. Radhakrishnan, 2024, The Journal of Nuclear Medicine.